Warnex to Host Annual Meeting April 29, 2008

Warnex Inc. (TSX: WNX) invites all interested parties to attend its Annual Meeting of Shareholders.

Date:        Tuesday, April 29, 2008

Time:        11:00 am (EST)

Location:    Sheraton Laval, Salon Chomedey
             2440 Autoroute des Laurentides
             Laval, Quebec

In addition to the formal business described in the Management Information Circular, Mark Busgang, President and CEO of Warnex, will present an update on corporate activities.

About Warnex

Warnex ( www.warnex.ca ) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex's analytical services division provides pharmaceutical and biotechnology companies with a variety of quality control services, including traditional chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex's bioanalytical services division specializes in bioequivalence and bioavailability studies for clinical trials. Warnex's medical laboratories division focuses on genetic and biochemical testing for the healthcare industry and has extensive expertise in genetic testing for human identification, molecular diagnostics, and pharmacogenetics.

Contacts: Warnex Inc. Mark J. Busgang President & CEO 450-663-6724 x 310 mbusgang@warnex.ca Warnex Inc. Catherine Sartoros Communications Specialist 450-663-6724 x 277 csartoros@warnex.ca